Occudo Quantitative Strategies’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.42M Buy
10,166
+3,613
+55% +$1.82M 0.24% 127
2025
Q4
$3.06M Buy
6,553
+3,945
+151% +$1.83M 0.2% 154
2025
Q3
$1.11M Buy
+2,608
New +$1.01M 0.14% 217
2025
Q1
Sell
-947
Closed -$284K 757
2024
Q4
$284K Sell
947
-10,250
-92% -$3.58M 0.05% 469
2024
Q3
$4.55M Buy
+11,197
New +$4.1M 0.83% 20
2024
Q2
Sell
-14,121
Closed -$4.71M 853
2024
Q1
$4.71M Buy
14,121
+6,192
+78% +$1.89M 0.82% 12
2023
Q4
$2.15M Buy
+7,929
New +$1.96M 0.29% 86
2023
Q3
Sell
-11,943
Closed -$3.62M 1112
2023
Q2
$3.62M Buy
+11,943
New +$3.32M 0.38% 40
2022
Q3
Sell
-6,974
Closed -$1.17M 1285
2022
Q2
$1.17M Buy
+6,974
New +$1.5M 0.1% 332
2021
Q4
Sell
-2,482
Closed -$602K 1140
2021
Q3
$602K Buy
+2,482
New +$607K 0.07% 475

Other funds holding HCA

Occudo Quantitative Strategies's HCA Position: Q1 2026 in Review

Occudo Quantitative Strategies increased its HCA Healthcare (HCA) stake by 55% in Q1 2026, buying an estimated $1.82M and bringing the position to 10,166 shares worth $4.42M. The position accounts for 0.24% of the portfolio, ranked #127.

Occudo Quantitative Strategies first reported a position in HCA in Q3 2021 and has held it in 10 quarters since. The position peaked at $4.71M in Q1 2024. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Occudo Quantitative Strategies held 10,166 shares of HCA Healthcare worth $4.42M as of Q1 2026.
  • Occudo Quantitative Strategies bought 3,613 HCA Healthcare shares in Q1 2026, an estimated $1.82M.
  • HCA Healthcare made up 0.24% of Occudo Quantitative Strategies's portfolio in Q1 2026, its #127 holding.
  • Occudo Quantitative Strategies first reported a position in HCA Healthcare in Q3 2021 and has held it in 10 quarters since.
  • Occudo Quantitative Strategies's HCA Healthcare position peaked at $4.71M in Q1 2024.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2026, filed 15 May 2026.